Media
Press releases
23Jun
Hansa Biopharma announces study design for a US randomized, controlled trial of imlifidase in highly sensitized kidney transplant patients
12May
Bulletin from the Annual General Meeting in Hansa Biopharma AB (publ)
22Apr
Regulatory press release
Hansa Biopharma interim report Jan-Mar 2021
Media assets
Executive Leadership Team
Dr Christian Kjellman
Senior Vice President, Chief Scientific Officer, Research and Development
